SG10202102293QA - A novel drug delivery system based on jcv-vlp - Google Patents

A novel drug delivery system based on jcv-vlp

Info

Publication number: SG10202102293QA
Authority: SG; Singapore
Prior art keywords: jcv; vlp; delivery system; drug delivery; system based
Prior art date: 2012-03-06

Application number

SG10202102293QA

Inventor

Victoria Demina

Heiko Manninga

Armin Götzke

Alexander Glassmann

Original Assignee

Life Science Inkubator Betr Gmbh & Co Kg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-03-06

Filing date

2013-03-06

Publication date

2021-04-29

2013-03-06 Application filed by Life Science Inkubator Betr Gmbh & Co Kg filed Critical Life Science Inkubator Betr Gmbh & Co Kg

2021-04-29 Publication of SG10202102293QA publication Critical patent/SG10202102293QA/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
- A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22023—Virus like particles [VLP]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22041—Use of virus, viral particle or viral elements as a vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22041—Use of virus, viral particle or viral elements as a vector
- C12N2710/22042—Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22041—Use of virus, viral particle or viral elements as a vector
- C12N2710/22043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
- C12N2710/22071—Demonstrated in vivo effect
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24023—Virus like particles [VLP]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24042—Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24071—Demonstrated in vivo effect
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Medicinal Chemistry (AREA)
General Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
Virology (AREA)
Molecular Biology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Microbiology (AREA)
Biophysics (AREA)
Epidemiology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Immunology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

SG10202102293QA 2012-03-06 2013-03-06 A novel drug delivery system based on jcv-vlp SG10202102293QA (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP12001507.8A EP2636746A1 (en)	2012-03-06	2012-03-06	A novel drug delivery system based on JCV-VLP

Publications (1)

Publication Number	Publication Date
SG10202102293QA true SG10202102293QA (en)	2021-04-29

Family

ID=48047958

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
SG10201607358WA SG10201607358WA (en)	2012-03-06	2013-03-06	A novel drug delivery system based on jcv-vlp
SG10202102293QA SG10202102293QA (en)	2012-03-06	2013-03-06	A novel drug delivery system based on jcv-vlp
SG11201405255SA SG11201405255SA (en)	2012-03-06	2013-03-06	A novel drug delivery system based on jcv-vlp

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
SG10201607358WA SG10201607358WA (en)	2012-03-06	2013-03-06	A novel drug delivery system based on jcv-vlp

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SG11201405255SA SG11201405255SA (en)	2012-03-06	2013-03-06	A novel drug delivery system based on jcv-vlp

Country Status (25)

Country	Link
US (3)	US20150045417A1 (en)
EP (3)	EP2636746A1 (en)
JP (1)	JP6175080B2 (en)
KR (1)	KR102058488B1 (en)
CN (1)	CN104395475B (en)
AU (1)	AU2013230232B2 (en)
BR (1)	BR112014021497A2 (en)
CA (1)	CA2865564C (en)
CY (1)	CY1120150T1 (en)
DK (2)	DK2823048T3 (en)
EA (1)	EA035308B1 (en)
ES (2)	ES2658941T3 (en)
HK (1)	HK1208046A1 (en)
HR (1)	HRP20180221T1 (en)
HU (2)	HUE038284T2 (en)
LT (1)	LT2823048T (en)
MX (1)	MX354004B (en)
NO (1)	NO2823048T3 (en)
NZ (1)	NZ629255A (en)
PL (1)	PL2823048T3 (en)
PT (2)	PT2823048T (en)
SG (3)	SG10201607358WA (en)
SI (1)	SI2823048T1 (en)
TR (1)	TR201802849T4 (en)
WO (1)	WO2013131644A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3031821A1 (en) *	2014-12-08	2016-06-15	Life Science Inkubator	polyomavirus VLPs with a fusion protein
EP3031820A1 (en)	2014-12-08	2016-06-15	Life Science Inkubator	JC Polyomavirus VLP (virus-like particle) with a targeting peptide
WO2017072303A1 (en) *	2015-10-28	2017-05-04	Life Science Inkubator Gmbh	Use of vlp for the detection of nucleic acids
CN106048093A (en) *	2016-08-02	2016-10-26	北京思尔成生物技术有限公司	JC virus detection method, kit and application of kit
BR112019014209A2 (en) *	2018-12-18	2021-09-28	Neuway Pharma Gmbh	DRUG RELEASE SYSTEM, METHOD FOR SUPPLY, VIRUS-LIKE PARTICLES (VLP), COMPOSITION AND USE OF THE DRUG RELEASE SYSTEM
EP3670652A1 (en) *	2018-12-18	2020-06-24	NEUWAY Pharma GmbH	Vlp for the treatment of a lysosomal storage disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19543553B4 (en) *	1995-11-22	2009-04-09	Deutsches Primatenzentrum Gmbh	VP antigens of the JC virus
WO1998048841A1 (en)	1997-04-26	1998-11-05	Rpms Technology Limited	Use of papovavirus capsid protein for delivery of genetic material
DE19916224C1 (en)	1999-04-10	2000-06-21	November Ag Molekulare Medizin	Synthetic molecule for delivering active ingredient to cell, used e.g. to treat human immune deficiency virus infection, comprises the ingredient linked to VP2 or 3 peptide from polyoma virus
DE10131145B4 (en)	2001-06-28	2005-07-14	Innovent E.V.	Composition for cell-specific transfer of active ingredients
WO2003106626A2 (en) *	2002-06-12	2003-12-24	Temple University Of The Commonwealth System Of Higher Education	Method of cell growth inhibition with agnoprotein
EP2036980A1 (en)	2007-09-14	2009-03-18	Gruber, Jens	Down regulation of gene expression using virus-like particles charged with nucleic acid
EP2093780B1 (en)	2008-02-22	2014-11-05	ABB Technology AG	A spring drive unit, an operating device for an electrical switching apparatus, and method for charging and/or discharging a spring in an operating device for an electrical switching apparatus
WO2010090757A1 (en) *	2009-02-05	2010-08-12	Biogen Idec Ma Inc.	Methods for the detection of jc polyoma virus

2012
- 2012-03-06 EP EP12001507.8A patent/EP2636746A1/en not_active Withdrawn
2013
- 2013-03-06 WO PCT/EP2013/000656 patent/WO2013131644A1/en active Application Filing
- 2013-03-06 EP EP17200325.3A patent/EP3299468A1/en not_active Withdrawn
- 2013-03-06 EA EA201491636A patent/EA035308B1/en unknown
- 2013-03-06 ES ES13714195.8T patent/ES2658941T3/en active Active
- 2013-03-06 LT LTEP13714195.8T patent/LT2823048T/en unknown
- 2013-03-06 US US14/383,267 patent/US20150045417A1/en not_active Abandoned
- 2013-03-06 MX MX2014010651A patent/MX354004B/en active IP Right Grant
- 2013-03-06 CN CN201380013112.4A patent/CN104395475B/en active Active
- 2013-03-06 JP JP2014560272A patent/JP6175080B2/en active Active
- 2013-03-06 SI SI201330942T patent/SI2823048T1/en unknown
- 2013-03-06 HU HUE13714195A patent/HUE038284T2/en unknown
- 2013-03-06 NZ NZ629255A patent/NZ629255A/en not_active IP Right Cessation
- 2013-03-06 CA CA2865564A patent/CA2865564C/en active Active
- 2013-03-06 SG SG10201607358WA patent/SG10201607358WA/en unknown
- 2013-03-06 NO NO13714195A patent/NO2823048T3/no unknown
- 2013-03-06 AU AU2013230232A patent/AU2013230232B2/en not_active Ceased
- 2013-03-06 SG SG10202102293QA patent/SG10202102293QA/en unknown
- 2013-03-06 EP EP13714195.8A patent/EP2823048B1/en active Active
- 2013-03-06 PT PT137141958T patent/PT2823048T/en unknown
- 2013-03-06 BR BR112014021497A patent/BR112014021497A2/en not_active IP Right Cessation
- 2013-03-06 SG SG11201405255SA patent/SG11201405255SA/en unknown
- 2013-03-06 PL PL13714195T patent/PL2823048T3/en unknown
- 2013-03-06 KR KR1020147028123A patent/KR102058488B1/en active IP Right Grant
- 2013-03-06 DK DK13714195.8T patent/DK2823048T3/en active
- 2013-03-22 TR TR2018/02849T patent/TR201802849T4/en unknown
- 2013-03-22 PT PT130014913T patent/PT2774991T/en unknown
- 2013-03-22 DK DK13001491.3T patent/DK2774991T3/en active
- 2013-03-22 HU HUE13001491A patent/HUE038580T2/en unknown
- 2013-03-22 ES ES13001491.3T patent/ES2661389T3/en active Active
2015
- 2015-08-31 HK HK15108461.6A patent/HK1208046A1/en not_active IP Right Cessation
2018
- 2018-02-05 CY CY20181100133T patent/CY1120150T1/en unknown
- 2018-02-06 HR HRP20180221TT patent/HRP20180221T1/en unknown
- 2018-06-26 US US16/018,110 patent/US20180296700A1/en not_active Abandoned
2019
- 2019-03-15 US US16/354,739 patent/US11291735B2/en active Active

Also Published As

Publication number	Publication date
EP2636746A1 (en)	2013-09-11
US20150045417A1 (en)	2015-02-12
JP2015513550A (en)	2015-05-14
DK2774991T3 (en)	2018-03-12
HUE038284T2 (en)	2018-10-29
CN104395475A (en)	2015-03-04
ES2661389T3 (en)	2018-03-28
AU2013230232A1 (en)	2014-10-02
CN104395475B (en)	2018-11-16
WO2013131644A8 (en)	2013-12-12
MX354004B (en)	2018-02-08
NZ629255A (en)	2016-09-30
HK1208046A1 (en)	2016-02-19
EP2823048A1 (en)	2015-01-14
CA2865564A1 (en)	2013-09-12
ES2658941T3 (en)	2018-03-13
AU2013230232B2 (en)	2019-01-03
AU2013230232A9 (en)	2018-12-13
HRP20180221T1 (en)	2018-04-20
LT2823048T (en)	2018-02-26
MX2014010651A (en)	2015-05-15
SG11201405255SA (en)	2014-09-26
BR112014021497A2 (en)	2019-07-16
SI2823048T1 (en)	2018-04-30
PT2774991T (en)	2018-03-07
US11291735B2 (en)	2022-04-05
WO2013131644A1 (en)	2013-09-12
DK2823048T3 (en)	2018-02-12
US20190201549A1 (en)	2019-07-04
EP3299468A1 (en)	2018-03-28
JP6175080B2 (en)	2017-08-02
CA2865564C (en)	2021-06-08
SG10201607358WA (en)	2016-10-28
CY1120150T1 (en)	2018-12-12
EA201491636A1 (en)	2015-05-29
PL2823048T3 (en)	2018-05-30
PT2823048T (en)	2018-02-09
TR201802849T4 (en)	2018-03-21
NO2823048T3 (en)	2018-04-07
HUE038580T2 (en)	2018-10-29
KR102058488B1 (en)	2019-12-23
US20180296700A1 (en)	2018-10-18
EP2823048B1 (en)	2017-11-08
KR20150003186A (en)	2015-01-08
EA035308B1 (en)	2020-05-27

Publication	Publication Date	Title
HK1208388A1 (en)	2016-03-04	Drug delivery device
IL236746B (en)	2020-02-27	Drug delivery device
HK1206655A1 (en)	2016-01-15	Drug delivery device
HK1206654A1 (en)	2016-01-15	Drug delivery device
HRP20181707T1 (en)	2019-02-22	A drug delivery system
HK1205702A1 (en)	2015-12-24	Drug delivery device
EP2921152A4 (en)	2016-08-10	Drug dispensing system
HK1204258A1 (en)	2015-11-13	Drug dispensing system
HK1208046A1 (en)	2016-02-19	A novel drug delivery system based on jcv-vlp jcv-
ZA201309156B (en)	2015-02-25	Drug delivery system
HK1202465A1 (en)	2015-10-02	Drug delivery device
SG10201609440WA (en)	2016-12-29	Multi-additive delivery system
HK1211246A1 (en)	2016-05-20	Drug delivery device
HK1206656A1 (en)	2016-01-15	Arrangement for a drug delivery device
HK1205704A1 (en)	2015-12-24	Drug delivery device
EP2917860A4 (en)	2016-06-22	Drug dispensing system
GB2504558B8 (en)	2016-08-03	A delivery aid
HUE049542T2 (en)	2020-10-28	Drug delivery device
HUE049546T2 (en)	2020-09-28	Drug delivery device